The synthetic opioid fentanyl, a substance capable of causing death with just a single dose, presents a grave and often…
Read More
VERTANICAL’s Investigational Non-Opioid Chronic Low Back Pain Treatment VER-01 Receives FDA Breakthrough Therapy Designation
VERTANICAL has announced a significant milestone in its development of VER-01, an investigational non-opioid therapeutic candidate for chronic low back…
Read More
Penn Researchers Develop Breakthrough Non-Addictive Gene Therapy Targeting Brain Pain Circuits to Combat Chronic Pain and Opioid Crisis
A new preclinical study has identified a gene therapy that directly targets pain-processing areas in the brain while avoiding the…
Read MoreYOU MAY HAVE MISSED
